Found 8 hits for monomerid = 50424473 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 300 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Displacement of [3H]-CP55,940 from human CB2 receptor expressed in Sf9 cell membranes by scintillation counting analysis |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 37 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Displacement of [3H]-CP55,940 from human CB1 receptor expressed in HEK293S cell membranes by scintillation counting analysis |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 47 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Displacement of [3H]-CP55,940 from human CB1 receptor expressed in HEK293S cell membranes by scintillation counting analysis |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 120 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in HEK293S cell membranes after 1 hr by GTPgamma[35S] binding assay |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP2C9 expressed in Escherichia coli cells |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | >2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human recombinant CYP3A4 expressed in Escherichia coli cells |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 32 | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Agonist activity at human CB1 receptor expressed in HEK293S cell membranes after 1 hr by GTPgamma[35S] binding assay |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |
Potassium voltage-gated channel subfamily H member 2
(Homo sapiens (Human)) | BDBM50424473
(CHEMBL2316385)Show SMILES CS(=O)Cc1ccc(C(=O)Nc2nccnc2C(=O)NCC2CCC2)c2ccccc12 Show InChI InChI=1S/C23H24N4O3S/c1-31(30)14-16-9-10-19(18-8-3-2-7-17(16)18)22(28)27-21-20(24-11-12-25-21)23(29)26-13-15-5-4-6-15/h2-3,7-12,15H,4-6,13-14H2,1H3,(H,26,29)(H,25,27,28) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Similars
| Article PubMed
| n/a | n/a | 1.70E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca
Curated by ChEMBL
| Assay Description Inhibition of human ERG expressed in CHO cells by patch clamp assay |
J Med Chem 56: 220-40 (2013)
Article DOI: 10.1021/jm301511h BindingDB Entry DOI: 10.7270/Q2057H7B |
More data for this Ligand-Target Pair | |